Tue.May 21, 2024

article thumbnail

How doctors are pressuring sickle cell patients into unwanted sterilizations

STAT

BATON ROUGE, La. — The surgery was supposed to alleviate worry, but now, years later, Whitney Carter’s mind kept flicking back to it, wondering if it could be undone. She sometimes descended into these moods, taciturn, withdrawn, as if all hope had gone extinct. She sat on the couch in the half-light, blinds shut against the heat. The whole thing made her feel less than, like some essential part of her had been removed.

364
364
article thumbnail

3 up-and-coming US biotech hotspots

PharmaVoice

These three U.S. cities are putting themselves on the biotech map as unsung hubs of the industry.

291
291
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Move over, wastewater. Store-bought milk could be another way to track the bird flu outbreak in cows

STAT

Scientists from the University of Washington and the Fred Hutchinson Cancer Center have managed to generate a full genetic sequence of H5N1 virus from milk, a development they suggest means commercially purchased milk products could be used to monitor the progress of the bird flu outbreak in dairy cattle and to check for important changes in the virus over time.

364
364
article thumbnail

After Vyvanse patent loss, Takeda’s neuroscience division looks to enter a new era

PharmaVoice

Heather Dean discusses the company’s neuroscience pipeline in epilepsy and narcolepsy and moving from a mass market to a rare disease mentality.

130
130
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

CDC asks states and cities to keep flu surveillance at peak levels because of bird flu threat

STAT

The Centers for Disease Control and Prevention asked local and state health officials Tuesday to maintain flu surveillance operations at peak-season levels over the summer in a bid to remain watchful for any signs of human-to-human spread of the H5N1 bird flu virus. Flu surveillance activity is generally conducted at low levels during the late spring and summer months, in recognition of the fact that as temperatures rise, transmission of seasonal flu viruses drops to minimal levels in the Northe

363
363
article thumbnail

April 2024 Newsletter

Safe Biologics

ASBM’s Michael Reilly: Preserve the US Interchangeable Standard that Has Helped Drive Physician and Patient Confidence in Biosimilars In an April interview with EndpointsNews , an FDA official called on Congress to eliminate the distinction between biosimilars (which can be prescribed in place of their reference products by a physician) and “interchangeable” biosimilars, which can be substituted by pharmacists the way generics are.

More Trending

article thumbnail

GP pharmacists in Wales to get structured induction programme

The Pharmacist

Pharmacists and pharmacy technicians transitioning to new roles in primary care are to be supported with a structured induction programme developed by Health Education and Improvement Wales (HEIW), it has said. The commitment came as part of the Welsh Government’s Strategic Workforce Plan for Primary Care for 2024/25-2029/30, published last week. The plan also committed […] The post GP pharmacists in Wales to get structured induction programme appeared first on The Pharmacist.

article thumbnail

STAT+: GSK’s asthma push continues as drug succeeds in Phase 3 trials

STAT

A new asthma treatment that could be administered just once every six months has succeeded in two Phase 3 trials, developer GlaxoSmithKline announced Tuesday. The drug, depemokimab, is designed to treat asthma by targeting a protein called interleukin-5, or IL-5. The protein is linked to the type of inflammation found in most severe asthma cases, according to the pharma company.

326
326
article thumbnail

Three-quarters of people with learning disability not registered for GP practice support

The Pharmacist

Three-quarters of people with a learning disability are not currently on the general practice learning disability register, a new report published today by the Women and Equalities Committee (WEC) has suggested. MPs on the cross-party committee warned that people with a learning disability and autistic people faced significant health inequalities, including an ‘unacceptable level of […] The post Three-quarters of people with learning disability not registered for GP practice support appear

118
118
article thumbnail

Opinion: As a primary care physician, here’s how I hope to partner with AI

STAT

I am both excited and terrified by the entrance of artificial intelligence into my primary care practice. AI’s enormous potential to help clinicians become more focused on patients, available, diagnostically accurate, and efficient feels like a dream. Yet memories of the nightmarish introduction of the electronic heath record into clinicians’ work lives looms like a dark cloud.

337
337
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

FDA competition seeks digital endpoints for Parkinson’s

pharmaphorum

FDA is asking artificial intelligence teams to develop a digital endpoint tool to study freezing of gait, a symptom of Parkinson’s that can have a serious impact on patients.

116
116
article thumbnail

STAT+: At a flashy new research hub, AstraZeneca lays out ambitious growth goals

STAT

CAMBRIDGE, England — On a bit of a roll, AstraZeneca on Tuesday laid out ambitious growth goals for the rest of the decade, seeking to build on its momentum in fields like oncology as it said it would nearly double its revenue to $80 billion by 2030. Hitting such a target would depend on the launch of 20 new medicines and continued growth of its cancer and rare disease therapies, as well as other drugs.

330
330
article thumbnail

AstraZeneca sets lofty target of $80bn in revenues by 2030

pharmaphorum

AstraZeneca CEO Pascal Soriot says group revenues can reach $80bn by 2030, fuelled by a pipeline that features 'many' potential $5bn-plus candidates.

118
118
article thumbnail

A letter from the executive editor: Investigation reveals how doctors have pressured sickle cell patients into sterilizations

STAT

Dear Readers, I want to bring your attention to a deeply disturbing but vital series of stories STAT is publishing beginning today.  It reveals that an injustice often relegated to the distant past persists to this day: For decades, physicians have steered sickle cell patients toward sterilization, their stories echoing the ugly history of eugenics in America.

314
314
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Novel biologic could offer ulcerative colitis symptomatic remission

European Pharmaceutical Review

Initial data from a Phase III maintenance study of TREMFYA ® (guselkumab) has demonstrated promising remission rates obtained from a dual-acting monoclonal antibody given to ulcerative colitis (UC) patients. This data from Johnson & Johnson’s Phase III QUASAR study is being presented at Digestive Disease Week 2024 (Abstract #759). Achievement of clinical remission Fifty percent of patients with moderate to severe active ulcerative colitis given subcutaneous TREMFYA (guselkumab) 200mg every f

105
105
article thumbnail

Opinion: Reports of telehealth’s death have been greatly exaggerated

STAT

“Telehealth is collapsing.” “Telehealth is going through a contraction.” “There is a dark cloud hovering over virtual care.” These are just a few of the doomsday views sparked by the news that Optum and Walmart are shutting down their virtual care businesses. Many industry observers, connecting the dots to the current struggles of legacy telehealth providers , have concluded that virtual care is in trouble.

321
321
article thumbnail

AstraZeneca sets sights on $80B in revenue by 2030

BioPharma Dive

The U.K. pharma expects to launch 20 new drugs by then, among them complex medicines for cancer as well as treatments for weight loss.

119
119
article thumbnail

STAT+: AltruBio raises $225 million to develop ulcerative colitis drug and other immune checkpoint enhancers

STAT

Checkpoint inhibitors, drugs that unleash the immune system, have turned into blockbuster therapies that have transformed outcomes for some patients with deadly cancers. AltruBio, a Bay Area biotech, is betting it can help patients suffering from autoimmune and inflammatory diseases by taking the opposite tack: pumping the brakes on runaway immune responses.

article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

AltruBio lands up to $225M after shift to immune drug research

BioPharma Dive

Since pivoting from oncology, the startup has raised close to $300 million and advanced an ulcerative colitis drug into mid-stage testing.

article thumbnail

Lilly doubles down on radiopharma

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning. Please take some time today to read  this story  from my colleague Eric Boodman, who spent a year investigating how doctors are pushing sickle cell patients to get unwanted sterilizations. This is the first story in a new series from STAT called  Coercive Care.

article thumbnail

AstraZeneca’s $80B sales plan leans on cancer drug expansion

BioPharma Dive

The U.K. drugmaker aims to catch up in developing new tumor-fighting technologies — areas where it has lagged behind leaders like Novartis and J&J.

102
102
article thumbnail

STAT+: Pharmalittle: We’re watching BIO layoffs, AstraZeneca plans to double revenue, and more

STAT

Good morning from the Pharmalittle campus, where I’m filling in for Ed. Normally, I’m the type of person who used to press snooze 10 times in their dorm room before running across campus to arrive for class barely on time. But this week, I’m up early. The scent of strong, dark roast espresso is just beginning to travel up my nasal passages to my brain.

251
251
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

One in 20 adults in UK have clinically confirmed food allergy

The Pharmacist

More than one in 20 adults in the UK has a clinically confirmed food allergy, according to a detailed study commissioned by the Food Standards Agency. The Patterns and Prevalence of Adult Food Allergy report also found that around 36% of people have a self-reported adverse reaction to food. For UK adults, peanuts and tree nuts like […] The post One in 20 adults in UK have clinically confirmed food allergy appeared first on The Pharmacist.

article thumbnail

Glenmark and BeiGene partner to market cancer drugs in India

Express Pharma

Glenmark Specialty S.A. (Glenmark), a subsidiary of Glenmark Pharmaceuticals., announced an exclusive marketing and distribution agreement with BeiGene. Under this agreement, Glenmark will register and commercialise BeiGene’s oncology medicines, Tislelizumab and Zanubrutinib in India. Tislelizumab is a novel anti-PD-1 monoclonal antibody approved by NMPA, EMA and FDA for the treatment of advanced or metastatic esophageal squamous cell carcinoma and broad development for the treatment of va

104
104
article thumbnail

EU rules PTC’s Duchenne drug can stay on the market

pharmaphorum

Going against the advice of the CHMP, the EU has said that PTC Therapeutics’ Translarna therapy for Duchenne muscular dystrophy should stay on the market

105
105
article thumbnail

19 Pharmacy Certifications to Advance Your Practice

PioneerRx

As independent pharmacy continues to go clinical, you’ve probably found yourself considering adding a service, expanding a program, or in this case, tacking on.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

The commercialisation of quantum science in pharma

pharmaphorum

In today’s podcast, web editor Nicole Raleigh speaks with PASQAL’S technical business developer Europe, Krisztian Benyo, PhD, about the pharma applications and commercialisation of quantum science.

98
article thumbnail

New patent for Merck Sharp drug BELSOMRA

Drug Patent Watch

Annual Drug Patent Expirations for BELSOMRA Belsomra is a drug marketed by Merck Sharp Dohme and is included in one NDA. It is available from one supplier.

99
article thumbnail

Sanofi, Formation Bio and OpenAI announce collaboration

Express Pharma

Sanofi, Formation Bio and OpenAI are collaborating to build AI-powered software to accelerate drug development and bring new medicines to patients more efficiently. The three teams will bring together data, software and tuned models to develop custom, purpose-built solutions across the drug development lifecycle. Sanofi will leverage this partnership to provide access to proprietary data to develop AI models.

article thumbnail

NIHR awards HealthTech Research Centre Network £5m to advance health innovations

Pharma Times

The network will support the development, evaluation and adoption of innovative health and care technology

111
111
article thumbnail

AstraZeneca sets $80 billion revenue target by 2030

Express Pharma

AstraZeneca aims to reach $80 billion in revenue by 2030, up from $45.8 billion in 2023. This will be achieved through growth in its existing oncology, biopharmaceuticals, and rare disease portfolio, alongside the launch of 20 new medicines before the end of the decade. To drive sustained growth beyond 2030, the company will invest in new technologies and platforms.

102
102